Target intelligence / Profile preview

TLC domain-containing protein 3A (TLCD3A)

Target
TLCD3A
Molecular classification
Other, Membrane-associated protein, TLC domain family (TRAM/LAG1/CLN8 homology domain)
01

Overview

TLC domain-containing protein 3A (TLCD3A), also known as FAM57A or CT120, is a membrane-associated protein encoded by the TLCD3A gene located on chromosome 17 in humans. It is implicated in promoting lung carcinogenesis; knockdown or splice variants lacking part of the protein have been shown to inhibit lung cancer cell growth. TLCD3A is predicted to be involved in amino acid transport and glutathione metabolism, with interactions noted with SLC3A2 and a gamma-glutamyltranspeptidase-like protein. Expression is strongest in the pancreas and present at lower levels in various other tissues, suggesting a broader physiological role. Ortholog data indicates a potential function in lipid homeostasis. There is no established evidence that TLCD3A functions as a therapeutic target such as a receptor, enzyme, or transporter at this time[1][2][7].

Other names
FAM57AFLJ22282CT120Protein CT120Protein FAM57Afamily with sequence similarity 57 member Amembrane protein expressed in epithelial-like lung adenocarcinoma
02

Biological functions

Carcinogenesis (promotes lung cancer cell growth)Amino acid transportGlutathione metabolismLipid homeostasis (ortholog evidence)
03

Disease associations

Cancer (notably lung cancer)Sclerosteosis 1

Beyond the preview

Go deeper on TLC domain-containing protein 3A (TLCD3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLC domain-containing protein 3A (TLCD3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call